Domperidone Prices

Domperidone Price Trend, Index and Forecast

Track the latest insights on domperidone price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Domperidone Prices Outlook Q2 2025

• China: US$ 106085/MT
• India: US$ 47500/MT
• Poland: US$ 116960/MT
• Brazil: US$ 90170/MT
• Thailand: US$ 52780/MT

Domperidone Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the domperidone prices in China reached 106085 USD/MT in June. As per the domperidone price chart, upstream costs were impacted by changes in raw material availability and input pricing. Besides, the increasing incidence of gastrointestinal disorders and supportive indications such as nausea, gastroparesis, and chemotherapy-induced vomiting sustained steady demand. Moreover, China's push toward generics, combined with large-scale domestic production capabilities, also kept prices competitive.

During the second quarter of 2025, the domperidone prices in India reached 47500 USD/MT in June. In India, prices were largely shaped by supply-side dynamics and regulatory conditions. The availability of active pharmaceutical ingredients (APIs) remained steady, with local manufacturers maintaining production capacity. Imports of intermediate chemicals, however, were influenced by fluctuations in freight rates and shipping delays, which created uncertainty in landed costs. These logistical hurdles, compounded by periodic port congestion, contributed to maintaining pricing stability despite moderate shifts in raw material expenses.

During the second quarter of 2025, domperidone prices in Poland reached 116960 USD/MT in June. In Poland, prices were shaped primarily by demand dynamics within the pharmaceutical and healthcare sectors. The drug continued to see steady use in hospital and retail settings, though consumption patterns were moderated by cautious procurement from distributors and pharmacies. Public healthcare tenders influenced buying behavior, with cost-conscious procurement authorities seeking to manage budgets effectively amid broader healthcare spending constraints. Regulatory compliance also contributed to overall cost structures.            

During the second quarter of 2025, the domperidone prices in Brazil reached 90170 USD/MT in June. Currency fluctuations influenced pricing. Import contracts tied to the dollar made procurement costs sensitive to exchange rate volatility, often outweighing the impact of stable API prices. Distributors factored in these fluctuations when setting prices for downstream markets. Regulatory compliance and quality certification requirements also contributed to the overall cost structure. Brazilian health authorities maintained rigorous standards for imported pharmaceutical ingredients, and fulfilling these obligations added layers of inspection and documentation costs. Domestic logistics challenges, including inland transportation inefficiencies, further compounded expenses for distributors supplying urban and regional healthcare markets.

During the second quarter of 2025, the domperidone prices in Thailand reached 52780 USD/MT in June. In Thailand, domperidone prices during the second quarter of 2025 were shaped primarily by the healthcare sector’s steady procurement needs. The demand side was driven by consistent consumption in both hospital and retail pharmacy channels, as the drug remains widely prescribed for gastrointestinal treatments. Moreover, seasonal consumption patterns had only a limited effect on overall market activity.

Domperidone Prices Outlook Q2 2023

• China: US$ 104,792/MT

In the second quarter of 2023, the price of the domperidone in China reached 104,792 USD/MT by June.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the domperidone prices.

Global Domperidone Price Trend

The report offers a holistic view of the global domperidone pricing trends in the form of domperidone price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of domperidone, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed domperidone demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Domperidone Price Trend

Q2 2025:

Domperidone prices in Europe were shaped primarily by subdued demand trends in the pharmaceutical sector. Prescriptions for gastrointestinal treatments remained steady but did not witness any notable surge, as demand from hospitals and outpatient facilities continued at baseline levels. Producers benefitted from stable access to raw materials, as feedstock intermediates saw softer costs in line with global market corrections. This helped keep overall production economics under control. However, compliance with stringent European regulatory frameworks, including good manufacturing practices and pharmacovigilance protocols, added to operational and certification costs, which exerted moderate upward pressure on prices. Currency fluctuations within the eurozone also influenced procurement dynamics, especially for import-reliant distributors contracting in dollar-denominated agreements.

Q2 2023:

European domperidone prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed domperidone price information for a comprehensive list of countries.

North America Domperidone Price Trend

Q2 2025:

As per the domperidone price index, prices in North America were shaped by a balance between regulatory constraints and supply chain conditions. Demand from hospitals and specialty clinics remained stable, but overall growth was limited due to the drug’s controlled status in the region, which restricted wider distribution and usage. The steady prescription demand meant buyers continued to procure cautiously, often through established wholesale channels rather than large-scale purchases. Currency stability offered some protection against volatility, but the region continued to face pressures from pharmaceutical quality regulations and inspections. Producers and distributors were required to maintain strict adherence, which raised operating and certification costs. Domestic distribution also contributed to the pricing environment, as warehousing and long-haul trucking requirements in a vast geographical market added another layer of expense.

Q2 2023:

The analysis of domperidone prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific domperidone historical data within the United States and Canada can also be provided.

Middle East and Africa Domperidone Price Trend

Q2 2025:

The report explores the domperidone trends and domperidone price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

Q2 2023:

The report explores the domperidone pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on domperidone prices for countries can also be provided.

Asia Pacific Domperidone Price Trend

Q2 2025:

Prices during the second quarter of 2025 were shaped by a combination of demand conditions, supply availability, and regulatory developments. Consumption patterns across key markets such as China, India, and Southeast Asia remained stable, driven by persistent use of the drug in gastrointestinal treatments. However, hospitals and pharmacies demonstrated cautious procurement strategies, preferring shorter contracts and maintaining lean inventories due to uncertain trade conditions and fluctuating freight rates. On the supply side, the availability of active pharmaceutical ingredients from domestic producers in India and China kept the market well-supplied. Lower raw material costs stemming from bulk chemical production supported stable manufacturing economics. Logistics remained a critical driver of pricing dynamics. Market participants bore additional expenses tied to regulatory documentation and import clearances, reinforcing stability in price structures.

Q2 2023:

The domperidone pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This domperidone price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Domperidone Price Trend

Q2 2025:

As per the domperidone price index, prices in Latin America were shaped by a combination of muted demand growth, import dependencies, and regional logistical inefficiencies. The pharmaceutical sector across Brazil, Mexico, and other key markets reported moderate consumption levels, with procurement largely driven by hospital and retail pharmacy networks. End-use demand remained stable but not expansive, as regulatory limitations on domperidone usage in certain therapeutic segments tempered wider uptake.

Q2 2023:

The analysis of domperidone prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Domperidone Price Trend, Market Analysis, and News

IMARC's latest publication, “Domperidone Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the domperidone market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of domperidone at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed domperidone prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting domperidone pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Domperidone Industry Analysis

The global domperidone market size reached USD 638.45 Million in 2024. By 2033, IMARC Group expects the market to reach USD 916.60 Million, at a projected CAGR of 3.90% during 2025-2033.

• The increasing cases of gastrointestinal conditions, including gastritis, gastroesophageal reflux disease (GERD), and gastroparesis are significantly influencing the demand for domperidone. These conditions often cause vomiting and nausea, which domperidone effectively manages. According to an article published by the Hindustan Times, Gastroesophageal Reflux Disease or GERD is one of the most common digestive diseases in India, around 20-30% of the population is said to suffer from this condition. Over the last decade, there has been a significant increase in the proportion of younger patients especially those within the age range of 30-39 years, who have come to us with GERD.
• The growing aging population is more prone to chronic illnesses and digestive disorders which is leading to increased use of domperidone. Elderly patients often experience lower gastric emptying and other gastrointestinal issues, making domperidone a crucial part of their treatment regimen. According to the report by the United Nations Population Fund and the International Institute for Population Sciences, there were 149 million persons aged 60 years and above in 2022 (as of July), comprising around 10.5% of the country's population. And, by 2015, this population will double to 20.8%, with the absolute number at 347 million. By the end of the century, the elderly will constitute over 36% of the total population of the country.
• Cancer patients undergoing chemotherapy frequently suffer from vomiting and nausea as side effects. The extensive use of domperidone to alleviate these symptoms is supporting the growth of the market. Advances in cancer treatment protocols incorporating supportive care medications also enhance the demand for domperidone. According to NIH, cancer is among the leading causes of death worldwide. In 2022, there were almost 20 million new cases and 9.7 million cancer-related deaths worldwide. By, 2040, the number of new cancer cases per year is expected to rise to 29.9 million and the number of cancer-related deaths to 15.3 million.

Domperidone News

The report covers the latest developments, updates, and trends impacting the global domperidone industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in domperidone production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the domperidone price trend.

Latest developments in the domperidone industry:

• In March 2024, Bon Secours Maryview Medical Center unveiled a new addition to its medical services with the introduction of the LINX Reflux Management System to treat gastroesophageal reflux disease (GERD).
• In November 2023, Phanthom Pharmaceuticals Inc., a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced that the US Food and Drug Administration (FDA) has approved VOQUENZA (vonoprazan) tablets 10 mg and 20 mg, a novel potassium-competitive acid blocker (PCAB), as a new treatment for adults for the healing of all grades of Erosive Esophagitis, also known as Erosive GERD (gastroesophageal reflux disease), maintenance of healing of all grades of Erosive GERD, and relief of heartburn associated with Erosive Gerd.

Product Description

Domperidone refers to medication that majorly acts as a dopamine antagonist. It is employed to treat nausea and vomiting caused by different conditions, such as gastroenteritis, chemotherapy, and Parkinson’s disease. Domperidone works by blocking dopamine receptors in the gastrointestinal tract and the chemoreceptor trigger zone, which helps to alleviate nausea and vomiting. It enhances gastrointestinal motility, making it useful in treating gastroparesis and other digestive disorders where delayed stomach emptying is an issue. It is available in several forms, such as tablets, suspensions, and suppositories. It is generally well tolerated, but potential side effects such as dry mouth, abdominal cramps, and less commonly, cardiovascular effects such as arrhythmias. The use of domperidone is often regulated and monitored due to these risks. Patients need to follow their healthcare provider’s instructions and discuss any existing health conditions or medications to avoid adverse interactions.

Report Coverage

​​​​​​​
Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of domperidone pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting domperidone price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The domperidone price charts ensure our clients remain at the forefront of the industry.